Annual CAPEX
$17.95 M
+$8.89 M+98.15%
September 30, 2024
Summary
- As of February 27, 2025, ENTA annual capital expenditures is $17.95 million, with the most recent change of +$8.89 million (+98.15%) on September 30, 2024.
- During the last 3 years, ENTA annual CAPEX has risen by +$17.20 million (+2293.07%).
- ENTA annual CAPEX is now at all-time high.
Performance
ENTA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$8.74 M
-$206.00 K-2.30%
December 31, 2024
Summary
- As of February 27, 2025, ENTA quarterly capital expenditures is $8.74 million, with the most recent change of -$206.00 thousand (-2.30%) on December 31, 2024.
- Over the past year, ENTA quarterly CAPEX has increased by +$7.96 million (+1011.18%).
- ENTA quarterly CAPEX is now -2.30% below its all-time high of $8.95 million, reached on September 30, 2024.
Performance
ENTA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$25.91 M
+$7.96 M+44.34%
December 31, 2024
Summary
- As of February 27, 2025, ENTA TTM capital expenditures is $25.91 million, with the most recent change of +$7.96 million (+44.34%) on December 31, 2024.
- Over the past year, ENTA TTM CAPEX has increased by +$19.22 million (+287.29%).
- ENTA TTM CAPEX is now at all-time high.
Performance
ENTA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ENTA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +98.2% | +1011.2% | +287.3% |
| 3 y3 years | +2293.1% | +3384.1% | +3493.1% |
| 5 y5 years | +231.3% | +10000.0% | +3354.1% |
ENTA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2293.1% | -2.3% | >+9999.0% | at high | +3493.1% |
| 5 y | 5-year | at high | +2293.1% | -2.3% | >+9999.0% | at high | +3493.1% |
| alltime | all time | at high | >+9999.0% | -2.3% | >+9999.0% | at high | >+9999.0% |
Enanta Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $8.74 M(-2.3%) | $25.91 M(+44.3%) |
| Sep 2024 | $17.95 M(+98.1%) | $8.95 M(+36.8%) | $17.95 M(+73.2%) |
| Jun 2024 | - | $6.54 M(+292.2%) | $10.37 M(+73.5%) |
| Mar 2024 | - | $1.67 M(+111.9%) | $5.97 M(-10.7%) |
| Dec 2023 | - | $787.00 K(-42.5%) | $6.69 M(-26.2%) |
| Sep 2023 | $9.06 M(+326.3%) | $1.37 M(-36.4%) | $9.06 M(-0.8%) |
| Jun 2023 | - | $2.15 M(-9.7%) | $9.13 M(+26.3%) |
| Mar 2023 | - | $2.38 M(-24.5%) | $7.23 M(+46.9%) |
| Dec 2022 | - | $3.16 M(+119.6%) | $4.92 M(+131.4%) |
| Sep 2022 | $2.13 M(+183.3%) | $1.44 M(+472.5%) | $2.13 M(+194.7%) |
| Jun 2022 | - | $251.00 K(+239.2%) | $721.00 K(-17.0%) |
| Mar 2022 | - | $74.00 K(-79.6%) | $869.00 K(-6.1%) |
| Dec 2021 | - | $363.00 K(+1000.0%) | $925.00 K(+23.3%) |
| Sep 2021 | $750.00 K(-48.1%) | $33.00 K(-91.7%) | $750.00 K(-28.4%) |
| Jun 2021 | - | $399.00 K(+206.9%) | $1.05 M(+13.7%) |
| Mar 2021 | - | $130.00 K(-30.9%) | $921.00 K(-19.6%) |
| Dec 2020 | - | $188.00 K(-43.0%) | $1.15 M(-20.8%) |
| Sep 2020 | $1.45 M(-73.3%) | $330.00 K(+20.9%) | $1.45 M(+2.4%) |
| Jun 2020 | - | $273.00 K(-22.9%) | $1.41 M(-58.1%) |
| Mar 2020 | - | $354.00 K(-27.5%) | $3.37 M(-39.0%) |
| Dec 2019 | - | $488.00 K(+64.9%) | $5.52 M(+1.9%) |
| Sep 2019 | $5.42 M(+81.7%) | $296.00 K(-86.7%) | $5.42 M(-5.7%) |
| Jun 2019 | - | $2.23 M(-11.0%) | $5.74 M(+24.4%) |
| Mar 2019 | - | $2.51 M(+552.9%) | $4.62 M(+61.3%) |
| Dec 2018 | - | $384.00 K(-38.4%) | $2.86 M(-4.0%) |
| Sep 2018 | $2.98 M | $623.00 K(-43.5%) | $2.98 M(+15.0%) |
| Jun 2018 | - | $1.10 M(+46.5%) | $2.59 M(+16.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $752.00 K(+49.2%) | $2.23 M(+8.5%) |
| Dec 2017 | - | $504.00 K(+115.4%) | $2.06 M(-17.9%) |
| Sep 2017 | $2.51 M(-47.1%) | $234.00 K(-68.4%) | $2.51 M(-6.7%) |
| Jun 2017 | - | $741.00 K(+28.2%) | $2.69 M(+5.0%) |
| Mar 2017 | - | $578.00 K(-39.3%) | $2.56 M(-26.8%) |
| Dec 2016 | - | $953.00 K(+129.6%) | $3.49 M(-26.3%) |
| Sep 2016 | $4.74 M(+102.8%) | $415.00 K(-32.3%) | $4.74 M(-19.7%) |
| Jun 2016 | - | $613.00 K(-59.5%) | $5.90 M(+3.7%) |
| Mar 2016 | - | $1.51 M(-31.1%) | $5.69 M(+33.0%) |
| Dec 2015 | - | $2.20 M(+39.1%) | $4.28 M(+83.1%) |
| Sep 2015 | $2.34 M(+127.2%) | $1.58 M(+295.0%) | $2.34 M(+88.2%) |
| Jun 2015 | - | $400.00 K(+300.0%) | $1.24 M(+1.8%) |
| Mar 2015 | - | $100.00 K(-60.9%) | $1.22 M(-3.3%) |
| Dec 2014 | - | $256.00 K(-47.2%) | $1.26 M(+22.6%) |
| Sep 2014 | $1.03 M(+69.6%) | $485.00 K(+28.3%) | $1.03 M(+38.0%) |
| Jun 2014 | - | $378.00 K(+168.1%) | $745.00 K(+77.8%) |
| Mar 2014 | - | $141.00 K(+487.5%) | $419.00 K(-32.3%) |
| Dec 2013 | - | $24.00 K(-88.1%) | $619.00 K(+2.1%) |
| Sep 2013 | $606.00 K(+140.5%) | $202.00 K(+288.5%) | $606.00 K(+17.7%) |
| Jun 2013 | - | $52.00 K(-84.8%) | $515.00 K(+1.0%) |
| Mar 2013 | - | $341.00 K(+3000.0%) | $510.00 K(+117.0%) |
| Dec 2012 | - | $11.00 K(-90.1%) | $235.00 K(-6.7%) |
| Sep 2012 | $252.00 K(-43.4%) | $111.00 K(+136.2%) | $252.00 K(+78.7%) |
| Jun 2012 | - | $47.00 K(-28.8%) | $141.00 K(+50.0%) |
| Mar 2012 | - | $66.00 K(+135.7%) | $94.00 K(+235.7%) |
| Dec 2011 | - | $28.00 K | $28.00 K |
| Sep 2011 | $445.00 K(+1102.7%) | - | - |
| Sep 2010 | $37.00 K | - | - |
FAQ
- What is Enanta Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual CAPEX year-on-year change?
- What is Enanta Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Enanta Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals TTM CAPEX year-on-year change?
What is Enanta Pharmaceuticals annual capital expenditures?
The current annual CAPEX of ENTA is $17.95 M
What is the all time high annual CAPEX for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual capital expenditures is $17.95 M
What is Enanta Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, ENTA annual capital expenditures has changed by +$8.89 M (+98.15%)
What is Enanta Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of ENTA is $8.74 M
What is the all time high quarterly CAPEX for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly capital expenditures is $8.95 M
What is Enanta Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, ENTA quarterly capital expenditures has changed by +$7.96 M (+1011.18%)
What is Enanta Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of ENTA is $25.91 M
What is the all time high TTM CAPEX for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high TTM capital expenditures is $25.91 M
What is Enanta Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, ENTA TTM capital expenditures has changed by +$19.22 M (+287.29%)